| scholarly article | Q13442814 |
| P50 | author | Adriana H. Tremoulet | Q106637194 |
| P2093 | author name string | Chisato Shimizu | |
| Jane C Burns | |||
| Feng He | |||
| Sonia Jain | |||
| Shinsuke Hoshino | |||
| P2860 | cites work | Abnormal Myocardial Perfusion in Kawasaki Disease Convalescence | Q56965123 |
| Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure | Q57259661 | ||
| Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction | Q58070990 | ||
| Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis | Q64261888 | ||
| Histopathological study on Kawasaki disease with special reference to the relation between the myocardial sequelae and regional wall motion abnormalities of the left ventricle | Q68113272 | ||
| Coronary aneurysms in a young adult: report of a case suspected of Kawasaki disease | Q69656483 | ||
| Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm | Q71499456 | ||
| Cardiac biopsy of Kawasaki disease | Q71855572 | ||
| Long-term changes in collagen formation expressed by serum carboxyterminal propeptide of type-I procollagen and relation to left ventricular function after acute myocardial infarction | Q77149429 | ||
| Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12 | Q80123801 | ||
| Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease | Q80273098 | ||
| Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease | Q80579437 | ||
| Differential gene expression of S100 protein family in leukocytes from patients with Kawasaki disease | Q81663557 | ||
| Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping | Q82598708 | ||
| Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support | Q84658437 | ||
| Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers | Q87895868 | ||
| Myocardial Perfusion, Fibrosis, and Contractility in Children With Kawasaki Disease | Q91018945 | ||
| Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition | Q91594685 | ||
| Circulating Markers of Inflammation Persist in Children and Adults With Giant Aneurysms After Kawasaki Disease | Q92191425 | ||
| IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 | ||
| S100A12 (EN-RAGE) in monitoring Kawasaki disease | Q28191511 | ||
| Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction | Q28271905 | ||
| Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Q30235037 | ||
| Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease | Q30394049 | ||
| The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury | Q33231048 | ||
| Recognition of a Kawasaki disease shock syndrome | Q33765278 | ||
| Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography | Q34118475 | ||
| Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study | Q34314065 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| The IL-33/ST2 pathway: therapeutic target and novel biomarker | Q34776884 | ||
| Cardiovascular biomarkers in acute Kawasaki disease | Q35658781 | ||
| Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. | Q35991675 | ||
| Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation | Q37443866 | ||
| Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence. | Q37591377 | ||
| Personalized risk assessment of heart failure patients: more perspectives from transforming growth factor super-family members | Q38254742 | ||
| Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal. | Q38517255 | ||
| Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential | Q38540889 | ||
| Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms | Q39859562 | ||
| Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin | Q40626988 | ||
| Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease | Q42284496 | ||
| Galectin-3 is a marker of myocardial and vascular fibrosis in Kawasaki disease patients with giant aneurysms | Q44205483 | ||
| Tc-99m HMPAO WBC imaging to detect carditis and to evaluate the results of high-dose gamma globulin treatment in Kawasaki disease | Q44493098 | ||
| Importance of rigorous evaluation in comparative biomarker studies | Q45094446 | ||
| The Spectrum of Cardiovascular Lesions Requiring Intervention in Adults After Kawasaki Disease | Q46647404 | ||
| Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease | Q47223160 | ||
| Myocardial Perfusion Reserve Index in Children With Kawasaki Disease | Q47258165 | ||
| New equations and a critical appraisal of coronary artery Z scores in healthy children. | Q51637898 | ||
| Kawasaki disease in a pediatric intensive care unit: a case-control study. | Q51682355 | ||
| Kawasaki Disease. | Q53127745 | ||
| Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. | Q53135283 | ||
| Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview. | Q55610979 | ||
| P433 | issue | 1 | |
| P921 | main subject | Kawasaki disease | Q265936 |
| ejection fraction | Q641303 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | e014569 | |
| P577 | publication date | 2019-12-27 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction | |
| P478 | volume | 9 |
| Q101578623 | Cardiac magnetic resonance feature tracking of the right ventricle in convalescent Kawasaki disease in a large single center | cites work | P2860 |
Search more.